25 years of Gentian Diagnostics – From Norwegian innovation to global reach

19. Nov 2026 | 5 min read

25 years of Gentian Diagnostics – From Norwegian innovation to global reach

From two brothers and a small facility on a farm in Norway to an international diagnostics company. In 2026, we celebrate 25 years of scientific expertise, assay development and international growth. What began as an ambition to improve laboratory testing by making important biomarkers available on clinical chemistry platforms has grown into a company delivering diagnostic solutions to laboratories around the world.

 

From an idea to an international diagnostics company

Gentian Diagnostics was founded in 2001 by brothers Erling and Bård Sundrehagen. Starting in a small facility on a farm outside Moss, Norway, they set out to address a specific challenge in laboratory diagnostics: the need for reliable cystatin C testing on automated clinical chemistry analysers.

Their vision was to make important diagnostic tests more accessible and efficient by enabling laboratories to perform them on instruments already in routine use. This ambition laid the foundation for our development. In 2006, we launched our cystatin C immunoassay, marking an important milestone in Gentian’s journey.

Since 2006, we have expanded our expertise, product portfolio and international presence. Today, we employ more than 60 people, while our headquarters, research and development, and manufacturing operations remain firmly rooted in Norway.

for-facebook_WEB

 On 24 August 2022, Norway’s Minister of Health and Care Services, Ingvild Kjerkol, officially opened Gentian Diagnostics’ new office, research and production facilities in Moss, Norway. 

 

Norwegian assays in laboratories worldwide

At the heart of our work is the ability to translate scientific expertise into practical diagnostic solutions. Building on our proprietary nanoparticle technology and extensive experience in immunoassay development, we develop and manufacture assays for automated clinical chemistry platforms while exploring new opportunities in point-of-care and high-sensitivity testing. 

From chicken eggs to diagnostic assays 

One of the more surprising elements of our products involves something as familiar as a chicken egg. We have developed specialised expertise in avian antibodies (IgY), which are obtained from chicken egg yolks and used in several of our diagnostic assays. Combined with Gentian’s proprietary nanoparticle technology, these antibodies play an important role in the development of reliable immunoassays. This specialised approach has been part of our technological development for many years.

 

tech-heading

 

From one assay to a growing portfolio

Over the years, we have broadened our portfolio beyond cystatin C to include assays addressing kidney disease, infection and inflammation, as well as veterinary diagnostics. Through our own development and collaboration with global IVD partners, we work to make clinically relevant biomarkers more accessible and bring valuable diagnostic solutions to laboratories and healthcare professionals.

 

Built on collaboration and scientific expertise

From our beginnings in Moss, Norway, we have developed an international network of customers, distributors and industry partners. Our growth reflects not only technological development, but also close collaboration with laboratories, researchers, healthcare professionals and commercial partners. These relationships help us understand evolving diagnostic needs and develop solutions designed for routine laboratory workflows.

Today, we serve international markets through our own operations and partner network, while maintaining our core research, development and manufacturing activities in Norway.


20-years-celebration-3

 

Celebrating the past – looking to the future

Reaching 25 years gives us an opportunity to reflect on the people, partnerships and achievements that have shaped Gentian’s journey. We will continue to focus on improving our existing products, exploring new biomarkers and developing strategic partnerships to bring diagnostic solutions to the market.

With 25 years of experience in immunoassay development, we remain committed to making diagnostic testing more efficient and accessible, supporting laboratories and healthcare professionals in making informed clinical decisions to the benefits of the patients

From our beginnings on a farm in Norway to laboratories around the world, Gentian’s journey is a story of scientific curiosity, specialised expertise and a long-term commitment to better diagnostic testing.

As we celebrate this milestone, we thank our employees, customers, partners and everyone who has contributed to Gentian’s development over the past 25 years.

We look forward to the next chapter.

You may also read


25 years of Gentian Diagnostics – From Norwegian innovation to global reach

Nov 19, 2026

25 years of Gentian Diagnostics – From Norwegian innovation to global reach

From two brothers and a small facility on a farm in Norway to an international diagnostics company. In 2026,..

Canine CRP – Adding inflammatory assessment to routine health screening panels

Nov 10, 2026

Canine CRP – Adding inflammatory assessment to routine health screening panels

Added insight with CRP-testing in dogs Routine laboratory testing plays an important role in assessing the..

Beyond creatinine: Cystatin C at ASN Kidney Week 2026

Oct 13, 2026

Beyond creatinine: Cystatin C at ASN Kidney Week 2026

Meet the Cystatin C Company at ASN Kidney Week 2026 Kidney function assessment is evolving, and cystatin C is..